{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:17:12Z","timestamp":1790918232774,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"BC Cancer Strategic Priorities Fund Award"},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007052","name":"MSK Cancer Center","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.humpath.2020.02.006","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T21:02:40Z","timestamp":1588194160000},"page":"40-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Proteomic analysis of transitional cell carcinoma\u2013like variant of tubo-ovarian high-grade serous carcinoma"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8739-3879","authenticated-orcid":false,"given":"Basile","family":"Tessier-Cloutier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn R.","family":"Cochrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony N.","family":"Karnezis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Colborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0124-7323","authenticated-orcid":false,"given":"Jamie","family":"Magrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Talhouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Piskorz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela S.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall","family":"Greening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"du Bois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus","family":"Pfisterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Soslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Brenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg B.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.02.006_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004347-198703000-00004","article-title":"Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison","volume":"6","author":"Austin","year":"1987","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00000478-200404000-00004","article-title":"Transitional cell carcinoma of the ovary: a morphologic study of 100 cases with emphasis on differential diagnosis","volume":"28","author":"Eichhorn","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib3","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/0002-9378(93)90365-P","article-title":"Transitional cell carcinoma of the ovary: a matched control study of advanced-stage patients treated with cisplatin-based chemotherapy","volume":"168","author":"Gershenson","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.humpath.2020.02.006_bib4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/1097-0142(19890301)63:5<839::AID-CNCR2820630508>3.0.CO;2-U","article-title":"Transitional cell carcinoma in high-grade high-stage ovarian carcinoma. An indicator of favorable response to chemotherapy","volume":"63","author":"Robey","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2020.02.006_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/ajcp\/93.4.457","article-title":"Ovarian carcinomas with transitional cell carcinoma pattern","volume":"93","author":"Silva","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/gyno.1995.0010","article-title":"Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC)","volume":"59","author":"Sweeten","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2020.02.006_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2004.12.047","article-title":"Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel","volume":"97","author":"Kommoss","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2020.02.006_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ajcp\/109.2.173","article-title":"Clinicopathologic significance of transitional cell carcinoma pattern in nonlocalized ovarian epithelial tumors (stages 2-4)","volume":"109","author":"Costa","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0046-8177(96)90335-4","article-title":"Advanced stage transitional cell carcinoma of the ovary","volume":"27","author":"Hollingsworth","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/IGC.0b013e3181dd0110","article-title":"Prognostic relevance of uncommon ovarian histology in women with stage III\/IV epithelial ovarian cancer","volume":"20","author":"Mackay","year":"2010","journal-title":"Int J Gynecol Canc"},{"key":"10.1016\/j.humpath.2020.02.006_bib11","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2020.02.006_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/modpathol.2011.183","article-title":"Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma","volume":"25","author":"Soslow","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/PGP.0b013e31824d7445","article-title":"Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant brenner tumor","volume":"31","author":"Ali","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s004280000315","article-title":"Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins","volume":"438","author":"Riedel","year":"2001","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2020.02.006_bib15","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1097\/00000478-200311000-00005","article-title":"Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications","volume":"27","author":"Logani","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib16","series-title":"WHO classification of tumours of female reproductive organs","author":"Kurman","year":"2014"},{"key":"10.1016\/j.humpath.2020.02.006_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00004347-199304000-00007","article-title":"Ovarian Brenner tumors and transitional cell carcinoma: recent developments","volume":"12","author":"Roth","year":"1993","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib18","first-page":"179","article-title":"Transitional cell carcinoma and other transitional cell tumors of the ovary","volume":"1","author":"Roth","year":"1996","journal-title":"Anat Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","article-title":"WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma","volume":"44","author":"Al-Hussaini","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.02.006_bib20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/PGP.0000000000000274","article-title":"An immunohistochemical algorithm for ovarian carcinoma typing","volume":"35","author":"Kobel","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbapap.2014.10.003","article-title":"Proteomic developments in the analysis of formalin-fixed tissue","volume":"1854","author":"Gustafsson","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.humpath.2020.02.006_bib22","doi-asserted-by":"crossref","first-page":"34949","DOI":"10.1038\/srep34949","article-title":"Quantitative profiling of single formalin fixed tumour sections: proteomics for translational research","volume":"6","author":"Hughes","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.humpath.2020.02.006_bib23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/PGP.0000000000000538","article-title":"Tubo-ovarian transitional cell carcinoma and high-grade serous carcinoma show subtly different Immunohistochemistry profiles","volume":"38","author":"Magrill","year":"2019","journal-title":"Int J Gynecol Pathol."},{"key":"10.1016\/j.humpath.2020.02.006_bib24","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies","volume":"5","author":"Kobel","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.humpath.2020.02.006_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.humpath.2020.02.006_bib26","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.humpath.2020.02.006_bib27","series-title":"fastcluster: fast hierarchical, agglomerative clustering routines for R and Python","first-page":"18","volume":"53","author":"M\u00fcllner","year":"2013"},{"key":"10.1016\/j.humpath.2020.02.006_bib28","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/bioinformatics\/btm069","article-title":"pcaMethods--a bioconductor package providing PCA methods for incomplete data","volume":"23","author":"Stacklies","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.humpath.2020.02.006_bib29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1200\/JCO.2002.20.2.463","article-title":"Effect of BRCA mutations on the length of survival in epithelial ovarian tumors","volume":"20","author":"Ben David","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2020.02.006_bib30","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-linked and sporadic ovarian cancer","volume":"283","author":"Boyd","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.humpath.2020.02.006_bib31","first-page":"1120","article-title":"BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II)","volume":"58","author":"Husain","year":"1998","journal-title":"Canc Res"},{"key":"10.1016\/j.humpath.2020.02.006_bib32","first-page":"3547","article-title":"BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in\u00a0vivo","volume":"59","author":"Yuan","year":"1999","journal-title":"Canc Res"},{"key":"10.1016\/j.humpath.2020.02.006_bib33","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.humpath.2013.02.006","article-title":"Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance","volume":"44","author":"Lien","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/1471-2407-14-484","article-title":"The clinicopathological significance of neurogenesis in breast cancer","volume":"14","author":"Zhao","year":"2014","journal-title":"BMC Canc"},{"key":"10.1016\/j.humpath.2020.02.006_bib35","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1038\/ncomms7153","article-title":"UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1\u03b1","volume":"6","author":"Goto","year":"2015","journal-title":"Nat Commun"},{"issue":"Suppl 4","key":"10.1016\/j.humpath.2020.02.006_bib36","first-page":"9","article-title":"Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumors","volume":"21","author":"Kleiman","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2020.02.006_bib37","first-page":"13957","article-title":"UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma","volume":"8","author":"Yang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/ccd51e37-fdf3-466e-b79f-2c390df9ab28","article-title":"Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression","volume":"8","author":"Brait","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.humpath.2020.02.006_bib39","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.canep.2013.05.012","article-title":"Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma","volume":"37","author":"Tian","year":"2013","journal-title":"Canc Epidemiol"},{"key":"10.1016\/j.humpath.2020.02.006_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2013.04.011","article-title":"Rescue of silenced UCHL1 and IGFBP4 expression suppresses clonogenicity of giant cell tumor-derived stromal cells","volume":"336","author":"Fellenberg","year":"2013","journal-title":"Canc Lett"},{"key":"10.1016\/j.humpath.2020.02.006_bib41","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ijc.22025","article-title":"Silencing of the UCHL1 gene in human colorectal and ovarian cancers","volume":"119","author":"Okochi-Takada","year":"2006","journal-title":"Int J Canc"},{"key":"10.1016\/j.humpath.2020.02.006_bib42","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s13277-015-3902-4","article-title":"CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) and P53 mutation pattern in sporadic colorectal cancer","volume":"37","author":"Abdelmaksoud-Dammak","year":"2016","journal-title":"Tumour Biol: J Int Soc Oncodevelopmental Biol Med"},{"key":"10.1016\/j.humpath.2020.02.006_bib43","first-page":"662","article-title":"UCHL1 is a putative tumor suppressor in ovarian cancer cells and contributes to cisplatin resistance","volume":"4","author":"Jin","year":"2013","journal-title":"J Canc"},{"key":"10.1016\/j.humpath.2020.02.006_bib44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/exd.12490","article-title":"Merkel cell carcinoma: is this a true carcinoma?","volume":"23","author":"Jankowski","year":"2014","journal-title":"Exp Dermatol"},{"issue":"Suppl 4","key":"10.1016\/j.humpath.2020.02.006_bib45","doi-asserted-by":"crossref","first-page":"S356","DOI":"10.1016\/S1590-8658(11)60591-4","article-title":"Gruppo Italiano Patologi Apparato D, Societa Italiana di Anatomia Patologica e Citopatologia Diagnostica\/International Academy of Pathology Id. Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report","volume":"43","author":"Rindi","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.humpath.2020.02.006_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2559.1985.tb02431.x","article-title":"PGP 9.5, a new marker for human neuroendocrine tumours","volume":"9","author":"Rode","year":"1985","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.02.006_bib47","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1186\/s12885-016-2799-7","article-title":"Claudin-4 activity in ovarian tumor cell apoptosis resistance and migration","volume":"16","author":"Hicks","year":"2016","journal-title":"BMC Canc"},{"key":"10.1016\/j.humpath.2020.02.006_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anndiagpath.2014.10.003","article-title":"Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression","volume":"19","author":"Abd-Elazeem","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib49","first-page":"59","article-title":"Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through \u03b2-catenin","volume":"12","author":"Shang","year":"2014","journal-title":"Cell Commun Signal: CCS"},{"key":"10.1016\/j.humpath.2020.02.006_bib50","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1593\/neo.12942","article-title":"Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases","volume":"14","author":"Shang","year":"2012","journal-title":"Neoplasia (New York, NY)"},{"key":"10.1016\/j.humpath.2020.02.006_bib51","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s12032-014-0951-2","article-title":"Low expression of claudin-4: an indicator of recurrence in esophageal squamous cell carcinoma after Ivor Lewis esophagectomy?","volume":"31","author":"Shi","year":"2014","journal-title":"Med Oncol (Northwood, London, England)"},{"key":"10.1016\/j.humpath.2020.02.006_bib52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/mol.112.079798","article-title":"Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1","volume":"83","author":"Shang","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.humpath.2020.02.006_bib53","doi-asserted-by":"crossref","first-page":"7378","DOI":"10.1158\/0008-5472.CAN-05-1036","article-title":"Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity","volume":"65","author":"Agarwal","year":"2005","journal-title":"Canc Res"},{"key":"10.1016\/j.humpath.2020.02.006_bib54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2008.01.024","article-title":"Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer","volume":"109","author":"Konecny","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2020.02.006_bib55","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.22536","article-title":"Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE)","volume":"109","author":"Santin","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2020.02.006_bib56","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.biochem.68.1.649","article-title":"MCM proteins in DNA replication","volume":"68","author":"Tye","year":"1999","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.humpath.2020.02.006_bib57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/modpathol.2010.202","article-title":"Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary","volume":"24","author":"Ota","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib58","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3892\/or.2014.3094","article-title":"MCM7 serves as a prognostic marker in diffuse-type gastric adenocarcinoma and siRNA-mediated knockdown suppresses its oncogenic function","volume":"31","author":"Kang","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.humpath.2020.02.006_bib59","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.humpath.2016.07.013","article-title":"MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions","volume":"57","author":"Choy","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2020.02.006_bib60","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1038\/sj.onc.1209435","article-title":"Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis","volume":"25","author":"Honeycutt","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2020.02.006_bib61","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/sj.onc.1209134","article-title":"MCM7 amplification and overexpression are associated with prostate cancer progression","volume":"25","author":"Ren","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2020.02.006_bib62","first-page":"245","article-title":"Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance","volume":"33","author":"Nishihara","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.humpath.2020.02.006_bib63","first-page":"3585","article-title":"Immunohistochemical expression and prognostic significance of CCND3, MCM2 and MCM7 in Hodgkin lymhoma","volume":"31","author":"Marnerides","year":"2011","journal-title":"Anticancer Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720300472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720300472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:36:48Z","timestamp":1758645408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720300472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":63,"alternative-id":["S0046817720300472"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.02.006","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomic analysis of transitional cell carcinoma\u2013like variant of tubo-ovarian high-grade serous carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}